Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Cammarata

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Oncotarget|June 26, 2018
A pilot study of circulating microRNAs as potential biomarkers of Fabry diseaseGiuseppe Cammarata, Simone Scalia, Paolo Colomba, et al.
Haematologica|May 10, 2007
Loss of heterozygosity in acute leukemia: evidence of frequent submicroscopic deletionsCecilia Agueli, Rosaria Basiricò, Francesco Fabbiano, et al.
Oncotarget|March 1, 2018
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signsPaolo Colomba, Carmela Zizzo, Riccardo Alessandro, et al.
Biomed Research International|May 16, 2015
High variability of Fabry disease manifestations in an extended Italian familyGiuseppe Cammarata, Pasquale Fatuzzo, Margherita Stefania Rodolico, et al.
Kidney & Blood Pressure Research|August 13, 2018
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy AreaCarmela Zizzo, Alessandra Testa, Paolo Colomba, et al.
Gene|December 23, 2015
Molecular and clinical studies in five index cases with novel mutations in the GLA geneCarmela Zizzo, Ines Monte, Antonio Pisani, et al.
Biomedicines|August 26, 2022
Generation and Characterization of Novel iPSC Lines from a Portuguese Family Bearing Heterozygous and Homozygous <i>GRN</i> MutationsAna Rafaela Oliveira, Solange Martins, Giuseppe Cammarata, et al.
American Journal of Hematology|June 26, 2010
14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11aCecilia Agueli, Giuseppe Cammarata, Domenico Salemi, et al.
Leukemia Research|June 10, 2015
miR-155 regulative network in FLT3 mutated acute myeloid leukemiaDomenico Salemi, Giuseppe Cammarata, Cecilia Agueli, et al.
Aging|August 4, 2020
Pompe disease: pathogenesis, molecular genetics and diagnosisSimona Taverna, Giuseppe Cammarata, Paolo Colomba, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Oncotarget|June 26, 2018
A pilot study of circulating microRNAs as potential biomarkers of Fabry diseaseGiuseppe Cammarata, Simone Scalia, Paolo Colomba, et al.
Haematologica|May 10, 2007
Loss of heterozygosity in acute leukemia: evidence of frequent submicroscopic deletionsCecilia Agueli, Rosaria Basiricò, Francesco Fabbiano, et al.
Oncotarget|March 1, 2018
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signsPaolo Colomba, Carmela Zizzo, Riccardo Alessandro, et al.
Biomed Research International|May 16, 2015
High variability of Fabry disease manifestations in an extended Italian familyGiuseppe Cammarata, Pasquale Fatuzzo, Margherita Stefania Rodolico, et al.
Kidney & Blood Pressure Research|August 13, 2018
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy AreaCarmela Zizzo, Alessandra Testa, Paolo Colomba, et al.
Gene|December 23, 2015
Molecular and clinical studies in five index cases with novel mutations in the GLA geneCarmela Zizzo, Ines Monte, Antonio Pisani, et al.
Biomedicines|August 26, 2022
Generation and Characterization of Novel iPSC Lines from a Portuguese Family Bearing Heterozygous and Homozygous <i>GRN</i> MutationsAna Rafaela Oliveira, Solange Martins, Giuseppe Cammarata, et al.
American Journal of Hematology|June 26, 2010
14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11aCecilia Agueli, Giuseppe Cammarata, Domenico Salemi, et al.
Leukemia Research|June 10, 2015
miR-155 regulative network in FLT3 mutated acute myeloid leukemiaDomenico Salemi, Giuseppe Cammarata, Cecilia Agueli, et al.
Aging|August 4, 2020
Pompe disease: pathogenesis, molecular genetics and diagnosisSimona Taverna, Giuseppe Cammarata, Paolo Colomba, et al.
Pageof 3